1. Home
  2. HOWL vs LFS Comparison

HOWL vs LFS Comparison

Compare HOWL & LFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOWL
  • LFS
  • Stock Information
  • Founded
  • HOWL 2017
  • LFS 2001
  • Country
  • HOWL United States
  • LFS Japan
  • Employees
  • HOWL N/A
  • LFS N/A
  • Industry
  • HOWL Biotechnology: Pharmaceutical Preparations
  • LFS Other Consumer Services
  • Sector
  • HOWL Health Care
  • LFS Real Estate
  • Exchange
  • HOWL Nasdaq
  • LFS Nasdaq
  • Market Cap
  • HOWL 64.5M
  • LFS 74.8M
  • IPO Year
  • HOWL 2021
  • LFS 2025
  • Fundamental
  • Price
  • HOWL $0.93
  • LFS $5.02
  • Analyst Decision
  • HOWL Strong Buy
  • LFS
  • Analyst Count
  • HOWL 5
  • LFS 0
  • Target Price
  • HOWL $7.00
  • LFS N/A
  • AVG Volume (30 Days)
  • HOWL 732.3K
  • LFS 3.9M
  • Earning Date
  • HOWL 11-04-2025
  • LFS 01-01-0001
  • Dividend Yield
  • HOWL N/A
  • LFS N/A
  • EPS Growth
  • HOWL N/A
  • LFS 99.16
  • EPS
  • HOWL N/A
  • LFS 0.12
  • Revenue
  • HOWL N/A
  • LFS $76,556,507.00
  • Revenue This Year
  • HOWL N/A
  • LFS N/A
  • Revenue Next Year
  • HOWL N/A
  • LFS N/A
  • P/E Ratio
  • HOWL N/A
  • LFS $54.40
  • Revenue Growth
  • HOWL N/A
  • LFS 12.13
  • 52 Week Low
  • HOWL $0.60
  • LFS $1.58
  • 52 Week High
  • HOWL $2.38
  • LFS $12.49
  • Technical
  • Relative Strength Index (RSI)
  • HOWL 24.51
  • LFS N/A
  • Support Level
  • HOWL $0.89
  • LFS N/A
  • Resistance Level
  • HOWL $1.00
  • LFS N/A
  • Average True Range (ATR)
  • HOWL 0.11
  • LFS 0.00
  • MACD
  • HOWL -0.03
  • LFS 0.00
  • Stochastic Oscillator
  • HOWL 5.58
  • LFS 0.00

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

About LFS LEIFRAS Co. Ltd. American Depositary Shares

Leifras Co Ltd is a sports and social business company dedicated to youth sports and community engagement. It provide services related to the organization and operations of sports schools and sports events for children.

Share on Social Networks: